Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung transplantation. Recipient selection.

Andrew D Yu1, Edward R Garrity

  • 1Division of Pulmonary and Critical Care Medicine, Loyola University Medical Center, 2160 S. First Avenue, Building 54, Room 131A, Maywood, IL 60153, USA.

Chest Surgery Clinics of North America
|September 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the accuracy of the lung allocation score.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2021
Same author

Association of Transplant Center With Survival Benefit Among Adults Undergoing Heart Transplant in the United States.

JAMA·2019
Same author

Reply: Does Overtreatment of Heart Transplantation Candidates Exist?

Journal of the American College of Cardiology·2018
Same author

Geographic Variation in the Treatment of U.S. Adult Heart Transplant Candidates.

Journal of the American College of Cardiology·2018
Same author

Trends in the Use of Inotropes to List Adult Heart Transplant Candidates at Status 1A.

Circulation. Heart failure·2017
Same author

Potential impact of a shock requirement on adult heart allocation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2017
Same journal

New treatment modalities for end-stage emphysema.

Chest surgery clinics of North America·2003
Same journal

Cost effectiveness of lung volume reduction surgery.

Chest surgery clinics of North America·2003
Same journal

Results of lung volume reduction surgery for emphysema.

Chest surgery clinics of North America·2003
Same journal

Complications after lung volume reduction surgery.

Chest surgery clinics of North America·2003
Same journal

Operative techniques for lung volume reduction surgery.

Chest surgery clinics of North America·2003
Same journal

Patient selection for lung volume reduction surgery.

Chest surgery clinics of North America·2003
See all related articles

Newer tools improve mortality prediction for end-stage lung disease patients awaiting lung transplantation. This review examines updated data for better patient selection and treatment strategies.

Area of Science:

  • Pulmonology and Transplant Medicine
  • Medical Prognostics

Background:

  • International lung transplant guidelines were established in 1998.
  • Advances in medical research have introduced new prognostic tools.
  • Accurate mortality prediction is crucial for end-stage lung disease management.

Purpose of the Study:

  • To review recent studies on mortality prediction in end-stage lung disease.
  • To examine newer tools for predicting outcomes in specific lung diseases.
  • To update considerations for lung transplant patient selection.

Main Methods:

  • Literature review of studies published since 1998.
  • Analysis of mortality prediction tools for obstructive, restrictive, pulmonary vascular, and suppurative/bronchiectatic lung diseases.

Related Experiment Videos

  • Examination of alternative treatments, postoperative risks, and contraindications.

    • Main Results:

    • Newer tools offer improved accuracy in predicting mortality for lung disease patients.
    • Specific prognostic factors vary across different types of lung disease.
    • Updated considerations for treatment and surgical risks are identified.

    Conclusions:

    • Revised prognostic data enhances patient selection for lung transplantation.
    • Accurate prediction models are vital for optimizing transplant outcomes.
    • Continuous evaluation of prognostic tools is necessary in lung transplant medicine.